Sopharma AD-Sofia (XBUL:SFA) Total Stockholders Equity : лв803 Mil (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia Total Stockholders Equity?

Sopharma AD-Sofia's Total Stockholders Equity for the quarter that ended in Jun. 2024 was лв803 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sopharma AD-Sofia's Book Value per Share for the quarter that ended in Jun. 2024 was лв4.84. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sopharma AD-Sofia's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.45.

Sopharma AD-Sofia Total Stockholders Equity Historical Data

The historical data trend for Sopharma AD-Sofia's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Total Stockholders Equity Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

556.43

553.27

646.98

704.66

738.33

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															697.34	716.42	738.33	795.57	802.65

Sopharma AD-Sofia (XBUL:SFA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sopharma AD-Sofia's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(802.649	-	0)	/	165.736
	=	4.84

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sopharma AD-Sofia's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(252.369	+	112.507)	/	802.649
	=	0.45

Sopharma AD-Sofia Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.

Sopharma AD-Sofia Headlines

No Headlines